SELLAS Life Sciences Group Inc (NASDAQ: SLS) on Tuesday, soared 7.84% from the previous trading day, before settling in for the closing price of $2.04. Within the past 52 weeks, SLS’s price has moved between $0.83 and $2.48.
During the last 5-year period, the sales growth of Healthcare Sector giant was 45.94%. The company achieved an average annual earnings per share of 47.00%. With a float of $141.07 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of SELLAS Life Sciences Group Inc is 0.97%, while institutional ownership is 23.22%. The most recent insider transaction that took place on Nov 19 ’25, was worth 100,806. In this transaction Director of this company bought 63,400 shares at a rate of $1.59, taking the stock ownership to the 104,400 shares. Before that another transaction happened on Jun 12 ’25, when Company’s Director bought 10,000 for $1.48, making the entire transaction worth $14,800. This insider now owns 20,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.20% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
SELLAS Life Sciences Group Inc (SLS) is currently performing well based on its current performance indicators. A quick ratio of 8.28 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 5.77 million, which is a jump from its year-to-date volume of 2.97 million. As of the previous 9 days, the stock’s Stochastic %D was 87.50%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 74.31%, which indicates a significant decrease from 88.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.78, while its 200-day Moving Average is $1.64. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $2.33. Second resistance stands at $2.46. The third major resistance level sits at $2.61. If the price goes on to break the first support level at $2.05, it is likely to go to the next support level at $1.90. Should the price break the second support level, the third support level stands at $1.77.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
Market capitalization of the company is 313.37 million based on 142,442K outstanding shares. Right now, sales total 0 K and income totals -30,880 K. The company made 0 K in profit during its latest quarter, and -6,790 K in sales during its previous quarter.
